Roth Capital Assigns Buy On Masimo Following Patent Victory
In a research report released Friday, Roth Capital analyst Chris Lewis assigned a Buy rating on Masimo Corp. (NASDAQ:MASI) with a $29 price target, following the news that a federal jury ruled that Philips Electronics should pay Masimo $467 million for having infringed two patents related to MASI’s pulse oximetry technology.
Lewis noted, “While we are not overly surprised the ruling was in MASI’s favor, the verdict’s monetary magnitude is significantly larger than we had anticipated. With relatively little to lose at this point, Philips will likely exhaust all appeal possibilities before paying, which could likely drag on for multiple years.”
According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Chris Lewis has a total average return of -12.2% and a 36.4% success rate. Lewis has a -9.0% average return when recommending MASI, and is ranked #3258 out of 3315 analysts.